Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 181 Lymphoma 97 Lymphoma, Large B-Cell, Diffuse 96 Precursor Cell Lymphoblastic Leukemia-Lymphoma 79 Sarcoma 69 Hodgkin Disease 54 Lymphoma, Non-Hodgkin 41 Triple Negative Breast Neoplasms 37 Burkitt Lymphoma 36 Lymphoma, Mantle-Cell 32 Leukemia 32 Lymphoma, Follicular 30 Multiple Myeloma 28 Carcinoma, Hepatocellular 28 Neoplasm Metastasis 23 Ovarian Neoplasms 21 Neoplasms 21 Lymphoma, Large-Cell, Anaplastic 18 Osteosarcoma 17 Lymphoma, B-Cell 17 Prostatic Neoplasms 16 Neuroblastoma 15 Lymphoma, T-Cell, Peripheral 15 Urinary Bladder Neoplasms 14 Recurrence 13 Lymphoma, Large-Cell, Immunoblastic 13 Inflammatory Breast Neoplasms 13 Immunoblastic Lymphadenopathy 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Stomach Neoplasms 10

Interventions

Diathermy 20 Radiotherapy 11 Fluorouracil 4 Drug Therapy 4 Cisplatin 4 Radiation 3 Immune Checkpoint Inhibitors 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Solutions 2 Immunotherapy 2 Hyperthermia, Induced 2 Hydrogen Peroxide 2 Conization 2 Capecitabine 2 spartalizumab 1 anlotinib 1 Temozolomide 1 Saline Solution 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Oxaliplatin 1 Mitomycin 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Gemcitabine 1 Folfox protocol 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperthermia × Doxorubicin × Clear all

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡